A surprising new study suggests that an anti-aging drug could help protect people genetically predisposed to Alzheimer's disease. Researchers found that just four weeks of low-dose rapamycin improved brain blood flow in healthy middle-aged adults carrying the high-risk APOE4 gene variant, with women showing the strongest benefits.
This story was curated by Byte Panorama from reporting published by All Top News -- ScienceDaily. Our summary condenses the essential facts available at the time of collection; it does not reproduce the full article. Details, quotes and later updates may appear in the original report.